To determine whether miR-661 regulates metastasis of NSCLC through EMT process, we measured expression of epithelial markers E-cadherin and β-catenin as well as mesenchymal markers vimentin and fibronectin. The gene discussed is CDH1; the disease is non-small cell lung carcinoma.